- Type of paper
: Paper in journal
Title: Estrogen and progesterone receptor concentrations in
precarcinomatous and carcinomatous endometrium
- Authors:
- Jokanović, Ljubomir (143644)
- Cvrtila, Dragutin (59441)
- Klarić, Petar (119853)
- Bačić, Ante
- Ivičević-Bakulić, Tomislav
- Kanajet, Duško
Journal: In vivo
Number: 3-4
ISSN: 0352-5562
Volume: 31
Year: 1991
Pages: from 49 to 51
Number of references: 19
Language: hrvatski
Summary: Estrogen (ER) and progesterone (PR) receptors were
determined in67 samples of endometrial tissue. Twenty-five patients
developedendometrial carcinoma, 22 hyperplasia adenomatosa and 20
patientshad normal findings. In the group of patients with
endometrialcarcinoma 40% of ER+/PR+ tumors, 36% of ER-/PR- tumors, and
24%of ER-/PR+ tumors were found. Median test showed that there wereno
differences among ER concentrations (x2=2,822; p=0,2349), oramong PR
concentrations (x2=3,582; p=0,1668) in the groups ofpatients examined.
Keywords: Endometrium, estrogen receptor, progesterone receptor
- Type of paper
: Paper in journal
Title: Tumor marker determinations
- Authors:
- Lukinac, Ljerka
- Kusić, Zvonko
- Franceschi, Maja
- Pokrajac, Boris (35532)
- Bolanča, Ante (145512)
- Nothig-Hus, Dunja
Journal: Acta medica iugoslavica
Number: 3
ISSN: 1330-0164
Volume: 45
Year: 1991
Pages: from 245 to 250
Number of references: 18
Language: engleski
Summary: A combination of 2 or 3 tumor markers was determined in the
serumof 478 patients with various malignant tumors.
In the serum of 90 patients with breast cancer increased CA 15-3values were
found in 2/3 of patients with relapse or metastasesand in 1/4 of patients
without signs of tumor.
Keywords: TPA, CA 19-9, CA 15-3, IAP, tumor mrkers, TG
- Type of paper
: Summary in proceedings
Title: Circulating CA 15-3, CA M26 and CA M29 levels in
monitoring patients with advanced breast cancer
- Authors:
- Cvrtila, Dragutin (59441)
- Pokrajac, Boris (35532)
- Klarić, Petar (119853)
- Editors
- Klavins, J. V.
- Birkmayer, G. D.
- Pimentel, E.
Proceedings title: Journal of tumor marker oncology
Language: engleski
Place: Vienna, Austria
Year: 1992
ISBN/ISSN: 0886-3849
Pages: from 89 to 89
Meeting: The 9th international conference on human tumor markers
Held: from 09/06/92 to 09/09/92
Summary: Serum samples were taken from patients who developed
metastaticdisease. At the moment distant metastases became
clinicallyevident our results had shown the level of CA 15-3 to
besignificantly higher than the levels of both CA M26 and CAM29.Results
suggest marker CA 15-3 to be more sensitive than theother two. It seems
that CA 15-3 is more closely than the othertwo related to the clinical
status assessed in the follow-upperiod.
Keywords: Breast cancer, metastases, CA 15-3, CA M26, CA M29
- Type of paper
: Summary in proceedings
Title: CA 15-3, CEA, osteocalcin and PRL in clinical diagnosis
and monitoringpatients with breast cancer
- Authors:
- Vrbanec, Damir
- Cvrtila, Dragutin (59441)
- Pezerović, Dž.
- Editors
- Klavins, J. V.
- Birkmayer, G. D.
- Pimentel, E.
Proceedings title: Journal of tumor marker oncology
Language: engleski
Place: Vienna, Austria
Year: 1992
ISBN/ISSN: 0886-3849
Pages: from 98 to 98
Meeting: The 9th international conference on human tumor markers
Held: from 09/06/92 to 09/09/92
Summary: Serum concentrations of CA 15-3, CEA and prolactin were
measuredin patients with breast cancer. In a group of patients whodeveloped
bone metastases osteocalcin was measured also. At leastone of markers was
elevated in 83% of patients. CEA and CA 15-3values were higher in patients
with metastases, and significantlymore patients with metastases had
elevated levels of CA 15-3 thanCEA. Serum PRL levels were raised in 13% of
metastatic patients.Mean level of osteocalcin was higher in patients with
multiplebone metastases.
Keywords: Breast cancer, CA 15-3, CEA, osteocalcin, prolactin
- Type of paper
: Summary in proceedings
Title: Evaluation of CEA, CA 15-3, CA M26 and CA M29 tumor
markers in monitoring patients with breast cancer
- Authors:
- Cvrtila, Dragutin (59441)
- Vrbanec, Damir
- Pokrajac, Boris (35532)
- Editors
- Klavins, J. V.
- Birkmayer, G. D.
- Pimentel, E.
Proceedings title: Journal of tumor marker oncology
Language: engleski
Place: Vienna, Austria
Year: 1993
ISBN/ISSN: 0886-3849
Pages: from 104 to 104
Meeting: 10th international conference on human tumor markers
Held: from 09/08/93 to 09/11/93
Summary: Determination of CEA, CA 15-3, CA M26 and CA M29 in serum
ofpatients suffering from breast cancer were made. At the momentdistant
metastases became clinically evident results had shownthe frequency of
positive CA 15-3 to be higher than those of CEA,CA M26 and CA M29. The
ability to detect active disease in anorder of decreasing sensitivity was
CA 15-3 > CEA > CA M29 > CAM26 (0.61, 0.53, 0.51 and 0.47, respectively).
In advanceddisease CA M26 and CA M29 combined together exhibit
lowersensitivity (0.71) than CA 15-3 and CEA (0.79).
Keywords: Breast cancer, metastases, tumor markers
- Type of paper
: Summary in proceedings
Title: Circulating tumor marker levels in diagnosis and follow-up
of patients with breast cancer
- Authors:
- Vrbanec, Damir
- Cvrtila, Dragutin (59441)
- Reiner, Željko
- Pezerović, Dž.
- Gjadrov, K.
- Editors
- Klavins, J. V.
- Birkmayer, G. D.
- Pimentel, E.
Proceedings title: Journal of tumor marker oncology
Language: engleski
Place: Vienna, Austria
Year: 1993
ISBN/ISSN: 0886-3849
Pages: from 100 to 100
Meeting: 10th international conference on human tumor markers
Held: from 09/08/93 to 09/11/93
Summary: Tumor markers CA 15-3, CEA, osteocalcin (BGP) and
alkalinephosphatase (ALP) in patients with breast cancer were
determined.Significantly more patients who developed distant metastases
hadelevated levels of CA 15-3 than CEA (chi-square 4.251; p<0.04).Under
basal conditions, mean serum BGP levels of most patientsfall within the
normal range. In 9% of patients with multiplebone metastases BGP and ALP
levels were higher after the onset ofantiblastic treatment. After a peak at
1-2 months, bothparameters fall.
Keywords: Tumor markers, breast cancer, CA 15-3, CEA, osteocalcin
- Type of paper
: Summary in proceedings
Title: ONDANSETRON (ZOFRAN) AND QUALITY OF LIFE AT PATIENTS UNDER
CHEMOTHERAPY
- Authors:
- Klarić, Petar (119853)
- BOLF-BENKOVIĆ, LADA
- LEPUŠIĆ, D
- KUNA, K.
Proceedings title: PROCEEDINGS OECI CONFERENCE ON CANCER AND QUALITY OF LIFE
Language: engleski
Place: BLED, SLOVENIJA
Year: 1995
Pages: from XC92
Meeting: The 9th international conference on human tumor markers
Held: from 05/12/95 to 05/14/95
- Type of paper
: Summary in proceedings
Title: TUMOR MARKER CA 125 AND STAGING OF OVARIAN CARCINOMA
- Authors:
- Klarić, Petar (119853)
- KONČAR, M.
- HERMAN, R.
- VIGNJEVIĆ, D.
Proceedings title: ZBORNIK RADOVA I HRVATSKOG KONGRESA GINEKOLOGA I OPSTETRIČARA
Language: hrvatski
Place: Zagreb
Year: 1995
Meeting: I HRVATSKI KONGRES GINEKOLOGA I OPSTERIČARA
Held: from 06/28/95 to 06/30/95
- Type of paper
: Summary in proceedings
Title: STEROID RECEPTORS IN PRIMARY AND METASTATIC OVARIAN CANCER
- Authors:
- Klarić, Petar (119853)
- BOLF-BENKOVIĆ, LADA
- Jokanović, Ljubomir (143644)
- LEPUŠIĆ, D
Proceedings title: ZBORNIK RADOVA I HRVATSKOG KONGRESA GINEKOLOGA I OPSTETRIČARA
Language: hrvatski
Place: Zagreb
Year: 1995
Meeting: I HRVATSKI KONGRES GINEKOLOGA I OPSTERIČARA
Held: from 06/28/95 to 06/30/95
